tiprankstipranks
Summit Therapeutics PLC (SMMT)
NASDAQ:SMMT
US Market
SMMT
Summit Therapeutics
RESEARCH TOOLSreports
Want to see SMMT full AI Analyst Report?

Summit Therapeutics (SMMT) Stock News & Sentiment

1,902 Followers
Summit Therapeutics Joins Elite List of Trending Analyst Calls
Premium
Weekend Updates
Summit Therapeutics Joins Elite List of Trending Analyst Calls
2d ago
SMMT
3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22
Premium
Market News
3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22
7d ago
BSX
SMMT
Tyler Van Buren Reiterates Buy on Summit Therapeutics, Citing Stable Long-Term Sales Outlook and Attractive Risk/Reward Despite Higher Future OpEx
Premium
Ratings
Tyler Van Buren Reiterates Buy on Summit Therapeutics, Citing Stable Long-Term Sales Outlook and Attractive Risk/Reward Despite Higher Future OpEx
19d ago
SMMT
Summit Therapeutics Flags Significant Going-Concern Risk Amid Cash Shortfall and Uncertain Financing
Premium
Company Announcements
Summit Therapeutics Flags Significant Going-Concern Risk Amid Cash Shortfall and Uncertain Financing
23d ago
SMMT
Summit Therapeutics: Buy/High Risk Rating Reiterated as Analyst Sees Attractive Upside to Unchanged $40 Target Despite HARMONi-3 Interim Miss
Premium
Ratings
Summit Therapeutics: Buy/High Risk Rating Reiterated as Analyst Sees Attractive Upside to Unchanged $40 Target Despite HARMONi-3 Interim Miss
24d ago
SMMT
Positioning Ivonescimab to Anchor a ~$200B PD-1xVEGF Market: Early NSCLC Validation and Commercial Head Start Support Buy Rating on Summit
Premium
Ratings
Positioning Ivonescimab to Anchor a ~$200B PD-1xVEGF Market: Early NSCLC Validation and Commercial Head Start Support Buy Rating on Summit
2M ago
SMMT
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
Premium
Company Announcements
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
2M ago
RVMD
SMMT
More SMMT News >

SMMT News on the Web

Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally | The Motley Fool
Motley Fool
Neutral
Summit Therapeutics Joins Elite List of Trending Analyst Calls
TipRanks News
Bearish
Summit Therapeutics (SMMT) Downgraded to Neutral Amid Competitive Pressures
GuruFocus News
Bearish
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
TipRanks News
Neutral
Texas Instruments, Generac upgraded: Wall Street’s top analyst calls
TipRanks News
Neutral
Texas Instruments, Generac upgraded: Wall Street's top analyst calls
The Fly
Neutral
Summit Therapeutics (SMMT) Receives a Buy from Stifel Nicolaus
TipRanks News
Bearish
Summit Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TipRanks News
Bearish

News Score - Last 7 Days

Very Positive
SMMT
Sector Average
Media Buzz
This Week17 articles
Weekly Average8.5 articles
News Sentiment
This Week19%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SMMT’s Media Buzz Sentiment?
17 articles about SMMT were published this week. In an average week, 8.5 articles are published.
    What is SMMT’s weekly average amount of articles?
    In an average week, 8.5 articles about SMMT are published.
      What is SMMT’s News Sentiment?
      19% of articles about SMMT were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week